Antisense oligonucleotide (ASO) in SMA: from bench-to-bedside
What will be discussed:
- The science behind nusinersen.▼
- Exploring the clinical applications of nusinersen.
Meet the speaker:
Wildon Farwell, MD, MPH
Global Medical Head of Neuromuscular Diseases at Biogen, Cambridge, MA, USA.
Loading…
Please fill out the following information for your registration
Meet the speaker:
Wildon Farwell, MD, MPH
Global Medical Head of Neuromuscular Diseases at Biogen, Cambridge, MA, USA.